Julie C. Ribot

Julie C. Ribot

Auto-generated profile, based on publicly available information

Julie C. Ribot

Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 March 2009 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
JRJulie C Ribot
Julie C Ribot
ADAna Debarros
Ana Debarros
DPDick John Pang
Dick John Pang
JNJoana F Neves
Joana F Neves
VPVictor Peperzak
Victor Peperzak
BSBruno Silva-Santos
Bruno Silva-Santos

14 October 2020 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
JRJulie C. Ribot
Julie C. Ribot
NLNoëlla Lopes
Noëlla Lopes
BSBruno Silva-Santos
Bruno Silva-Santos

11 October 2019 in Science Immunology
Verified
Journal Article
Open access
PDF file
MRMiguel Ribeiro
Miguel Ribeiro
HBHelena C. Brigas
Helena C. Brigas
MTMariana Temido-Ferreira
Mariana Temido-Ferreira
PPPaula A. Pousinha
Paula A. Pousinha
TRTommy Regen
Tommy Regen
JRJulie C. Ribot
Julie C. Ribot
Meningeal γδ T cells are biased toward IL-17 production and control hippocampal synaptic plasticity and short-term memory.

1 June 2017 in Nature Immunology
Verified
Journal Article
Closed access
PPPedro H Papotto
Pedro H Papotto
JRJulie C Ribot
Julie C Ribot
BSBruno Silva-Santos
Bruno Silva-Santos

1 August 2021 in Cell Reports
Verified
Journal Article
Open access
HBHelena C. Brigas
Helena C. Brigas
MRMiguel Ribeiro
Miguel Ribeiro
JCJoana E. Coelho
Joana E. Coelho
RGRui Gomes
Rui Gomes
VGVictoria Gomez-Murcia
Victoria Gomez-Murcia
JRJulie C. Ribot
Julie C. Ribot
Neuroinflammation in patients with Alzheimer's disease (AD) and related mouse models has been recognized for decades, but the contribution of the recently described meningeal immune population to AD pathogenesis remains to be addressed. Here, using the 3xTg-AD model, we report an accumulation of interleukin-17 (IL-17)-producing cells, mostly γδ T cells, in the brain and the meninges of female, but not male, mice, concomitant with the onset of cognitive decline. Critically, IL-17 neutralization into the ventricles is sufficient to prevent short-term memory and synaptic plasticity deficits at early stages of disease. These effects precede blood-brain barrier disruption and amyloid-beta or tau pathology, implying an early involvement of IL-17 in AD pathology. When IL-17 is neutralized at later stages of disease, the onset of short-memory deficits and amyloidosis-related splenomegaly is delayed. Altogether, our data support the idea that cognition relies on a finely regulated balance of "inflammatory" cytokines derived from the meningeal immune system.

1 April 2013 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JCJonathan M. Coquet
Jonathan M. Coquet
JRJulie C. Ribot
Julie C. Ribot
NBNikolina Bąbała
Nikolina Bąbała
SMSabine Middendorp
Sabine Middendorp
GHGerda van der Horst
Gerda van der Horst
JBJannie Borst
Jannie Borst
CD4+Foxp3+ regulatory T cells (Treg cells) are largely autoreactive yet escape clonal deletion in the thymus. We demonstrate here that CD27–CD70 co-stimulation in the thymus rescues developing Treg cells from apoptosis and thereby promotes Treg cell generation. Genetic ablation of CD27 or its ligand CD70 reduced Treg cell numbers in the thymus and peripheral lymphoid organs, whereas it did not alter conventional CD4+Foxp3− T cell numbers. The CD27–CD70 pathway was not required for pre-Treg cell generation, Foxp3 induction, or mature Treg cell function. Rather, CD27 signaling enhanced positive selection of Treg cells within the thymus in a cell-intrinsic manner. CD27 signals promoted the survival of thymic Treg cells by inhibiting the mitochondrial apoptosis pathway. CD70 was expressed on Aire− and Aire+ medullary thymic epithelial cells (mTECs) and on dendritic cells (DCs) in the thymic medulla. CD70 on both mTECs and DCs contributed to Treg cell development as shown in BM chimera experiments with CD70-deficient mice. In vitro experiments indicated that CD70 on the CD8α+ subset of thymic DCs promoted Treg cell development. Our data suggest that mTECs and DCs form dedicated niches in the thymic medulla, in which CD27–CD70 co-stimulation rescues developing Treg cells from apoptosis, subsequent to Foxp3 induction by TCR and CD28 signals.